 |
|
|
| |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Integrated Week 96 Subgroup Analyses
|
| |
| |
Reported by Jules Levin
IAS 2013 June 30-July 3 Kuala Lumpur
D Cooper1, A Zolopa2, JK Rockstroh3, C Orkin4, HJ Stellbrink5,
S Walmsley6, L Zhong7, M Fordyce7, MS Rhee7, J Szwarcberg7
1St Vincent's Hospital, Sydney, Australia; 2Stanford University, Palo Alto, CA, US; 3University of Bonn, Bonn, Germany; 4Barts and the London NHS Trust, London, UK; 5ICH Study Center, Hamburg, Germany;
6Toronto General Hospital, Toronto, Canada; 7Gilead Sciences, Foster City, CA, US
|
| |
|
|
|
|
|
